Juliana Hilliard net worth
Quick answer
Juliana Hilliard's estimated net worth is $29.4M (range $20.58M – $44.1M) as of 2026. Juliana Hilliard is Founder at Parallel Bio. Parallel Bio valuation.
Juliana Hilliard is Founder at Parallel Bio (YC S21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Stanford University
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 20
- Website: http://parallel.bio
Who is Juliana Hilliard?
Juliana Hilliard is a founder at Parallel Bio, a company that leverages advanced AI for drug discovery. She participated in Y Combinator's S21 cohort.
Highlights:
- Y Combinator S21
- Research at Stanford University
- Published in scientific journals
About Parallel Bio
Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier, more reliable decisions about disease biology and drug development.
Parallel Bio’s platform overcomes the core limitations of traditional animal testing, which fails to...
FAQ: Juliana Hilliard net worth and Parallel Bio valuation
What is Juliana Hilliard's net worth?
Juliana Hilliard's estimated net worth is $29.4M (range $20.58M – $44.1M) as of 2026. Juliana Hilliard is Founder at Parallel Bio. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Parallel Bio valuation?
Parallel Bio's estimated valuation on Entrepreneurial Check is $210.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Juliana Hilliard's role?
Juliana Hilliard is Founder at Parallel Bio, a Y Combinator-backed startup (batch S21).